Want to see ISRG full AI Analyst Report?
ISRG Stock Chart & Stats
$469.21
$11.55(2.17%)
At close: 4:00 PM EST
$469.21
$11.55(2.17%)
Day’s Range― - ―
52-Week Range$342.10 - $603.88
Previous CloseN/A
Volume485.62K
Average Volume (3M)2.95M
Market Cap
$122.33B
Enterprise Value$161.44K
Total Cash (Recent Filing)$4.55B
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)42.2
Beta1.10
Next Earnings
Oct 20, 2026EPS Estimate
2.64Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)8.37
Shares Outstanding354,162,840
10 Day Avg. Volume4,024,980
30 Day Avg. Volume2,945,774
Financial Highlights & Ratios
PEG Ratio3.17
Price to Book (P/B)11.34
Price to Sales (P/S)20.08
P/FCF Ratio81.16
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price Target
$501.24Price Target Upside6.83% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering23
EPS Forecast (FY)10.74
Revenue Forecast (FY)$11.76B
Bulls Say, Bears Say
Bulls Say
Recurring Revenue MixA high share of recurring revenue (instruments, accessories, service) tied to an expanding installed base creates durable, predictable cash flows. This ‘razor-and-blades’ model supports long-term revenue visibility, better unit economics per procedure, and resilience to cyclical system-sales swings.
Strong Profitability And Cash FlowSustained high margins and robust free cash flow conversion provide durable internal funding for R&D, buybacks, and strategic investments. Strong cash generation reduces financing vulnerability and enables the company to support commercialization and clinical evidence initiatives over multiple years.
Conservative Balance SheetVery low leverage gives the company long-term optionality to invest in product development, absorb regional capital pressure, and execute buybacks or M&A without refinancing risk. This financial strength materially lowers solvency risk across business cycles.
Bears Say
Revenue Growth DecelerationA marked slowdown in top-line growth undermines the growth engine that feeds recurring instrument and service demand. If sustained, lower procedure expansion limits long-term revenue upside, pressures per-procedure instrument volumes, and raises execution risk for margin support assumptions.
China And International HeadwindsProlonged tender weakness, pricing pressure and slower regulatory clearances in large markets like China materially constrain placement growth and ASPs. These structural market dynamics can persist for quarters, capping global installed-base expansion and recurring revenue potential.
Extended-use Instruments RiskIf extended-use instruments materially reduce replacement frequency, recurring instruments & accessories revenue per procedure could decline. This structural shift would erode the core razor-and-blades economics unless offset by higher procedure volumes or new recurring offerings.
Intuitive Surgical News
ISRG FAQ
What was Intuitive Surgical’s price range in the past 12 months?
Intuitive Surgical lowest stock price was $342.10 and its highest was $603.88 in the past 12 months.
What is Intuitive Surgical’s market cap?
Intuitive Surgical’s market cap is $122.33B.
When is Intuitive Surgical’s upcoming earnings report date?
Intuitive Surgical’s upcoming earnings report date is Oct 20, 2026 which is in 91 days.
How were Intuitive Surgical’s earnings last quarter?
Intuitive Surgical released its earnings results on Jul 16, 2026. The company reported $2.8 earnings per share for the quarter, beating the consensus estimate of $2.511 by $0.289.
Is Intuitive Surgical overvalued?
According to Wall Street analysts Intuitive Surgical’s price is currently Undervalued.
Does Intuitive Surgical pay dividends?
Intuitive Surgical does not currently pay dividends.
What is Intuitive Surgical’s EPS estimate?
Intuitive Surgical’s EPS estimate is 2.64.
How many shares outstanding does Intuitive Surgical have?
Intuitive Surgical has 354,162,840 shares outstanding.
What happened to Intuitive Surgical’s price movement after its last earnings report?
Intuitive Surgical reported an EPS of $2.8 in its last earnings report, beating expectations of $2.511. Following the earnings report the stock price went down -14.145%.
Which hedge fund is a major shareholder of Intuitive Surgical?
Currently, no hedge funds are holding shares in ISRG
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Intuitive Surgical Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$501.24 (6.83% Upside)
$501.24 (6.83% Upside)
Blogger Sentiment
Bullish
ISRG Sentiment 70%
Sector Average 66%
Sector Average 66%
Hedge Fund Trend
Increased
By 83.7K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Positive
Last 7 Days ▲ 2.5%
Last 30 Days ▲ 9.0%
Last 30 Days ▲ 9.0%
News Sentiment
Neutral
Bullish news 59%
Bearish news 41%
Bearish news 41%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-33.07%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
3.54%
Trailing 12-Months
Company Description
Intuitive Surgical
Intuitive Surgical, Inc. is a leading medical technology firm dedicated to advancing patient care by developing, producing, and commercializing sophisticated tools. These innovations empower medical professionals to deliver superior, accessible, and less-invasive treatment options to patients both within the United States and across international markets. Its flagship offering, the da Vinci Surgical System, facilitates intricate operations through a minimally disruptive approach. Expanding beyond surgical applications, the company also provides the Ion endoluminal system, designed for diagnostic interventions like minimally invasive lung biopsies. Complementing its primary systems, Intuitive Surgical supplies a comprehensive array of instruments, including stapling tools, energy devices, and essential core components. Furthermore, it offers structured training programs to ensure proficient use of its technology, alongside extensive customer support services encompassing installation, repairs, and ongoing maintenance. The firm also integrates digital capabilities to deliver unified, connected solutions that optimize hospital performance through actionable insights. Established in 1995, Intuitive Surgical maintains its corporate headquarters in Sunnyvale, California.
ISRG Revenue Breakdown
67.72% U.S.
32.28% Outside of U.S
ISRG Stock 12 Month Forecast
Average Price Target
$501.24
▲(6.83% Upside)
Technical Analysis
Ownership Overview
0.47% Insiders
21.93% Mutual Funds
1.23% Other Institutional Investors
49.59% Public Companies and Individual Investors